Annual Working Capital
$427.35 M
+$32.06 M+8.11%
December 31, 2023
Summary
- As of February 7, 2025, ZNTL annual working capital is $427.35 million, with the most recent change of +$32.06 million (+8.11%) on December 31, 2023.
- During the last 3 years, ZNTL annual working capital has risen by +$110.85 million (+35.02%).
- ZNTL annual working capital is now at all-time high.
Performance
ZNTL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$345.39 M
-$27.53 M-7.38%
September 30, 2024
Summary
- As of February 7, 2025, ZNTL quarterly working capital is $345.39 million, with the most recent change of -$27.53 million (-7.38%) on September 30, 2024.
- Over the past year, ZNTL quarterly working capital has dropped by -$123.95 million (-26.41%).
- ZNTL quarterly working capital is now -32.56% below its all-time high of $512.17 million, reached on June 30, 2023.
Performance
ZNTL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ZNTL Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.1% | -26.4% |
| 3 y3 years | +35.0% | -26.4% |
| 5 y5 years | +1987.8% | -26.4% |
ZNTL Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +39.3% | -32.6% | +34.0% |
| 5 y | 5-year | at high | +691.5% | -32.6% | +603.9% |
| alltime | all time | at high | +1987.8% | -32.6% | +603.9% |
Zentalis Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $345.39 M(-7.4%) |
| Jun 2024 | - | $372.92 M(-16.9%) |
| Mar 2024 | - | $449.01 M(+5.1%) |
| Dec 2023 | $427.35 M(+8.1%) | $427.35 M(-8.9%) |
| Sep 2023 | - | $469.35 M(-8.4%) |
| Jun 2023 | - | $512.17 M(+44.7%) |
| Mar 2023 | - | $353.87 M(-10.5%) |
| Dec 2022 | $395.29 M | $395.29 M(+4.1%) |
| Sep 2022 | - | $379.83 M(-9.3%) |
| Jun 2022 | - | $418.99 M(+62.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $257.80 M(-16.0%) |
| Dec 2021 | $306.83 M(-3.1%) | $306.83 M(-9.3%) |
| Sep 2021 | - | $338.15 M(+49.7%) |
| Jun 2021 | - | $225.87 M(-17.4%) |
| Mar 2021 | - | $273.56 M(-13.6%) |
| Dec 2020 | $316.50 M(+486.2%) | $316.50 M(-9.3%) |
| Sep 2020 | - | $348.83 M(+56.5%) |
| Jun 2020 | - | $222.91 M(+354.3%) |
| Mar 2020 | - | $49.07 M(-9.1%) |
| Dec 2019 | $53.99 M(+163.8%) | $53.99 M |
| Dec 2018 | $20.47 M | - |
FAQ
- What is Zentalis Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals annual working capital year-on-year change?
- What is Zentalis Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals quarterly working capital year-on-year change?
What is Zentalis Pharmaceuticals annual working capital?
The current annual working capital of ZNTL is $427.35 M
What is the all time high annual working capital for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high annual working capital is $427.35 M
What is Zentalis Pharmaceuticals annual working capital year-on-year change?
Over the past year, ZNTL annual working capital has changed by +$32.06 M (+8.11%)
What is Zentalis Pharmaceuticals quarterly working capital?
The current quarterly working capital of ZNTL is $345.39 M
What is the all time high quarterly working capital for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high quarterly working capital is $512.17 M
What is Zentalis Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, ZNTL quarterly working capital has changed by -$123.95 M (-26.41%)